Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

Brief Report

(2020) Katherine E. Bunge et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

End‐user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study

(2019) Elizabeth T Montgomery et al.   Journal of the International AIDS Society

HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial

(2019) Khatija Ahmed et al.   LANCET

Current and Future PrEP Medications and Modalities: On-demand, Injectables, and Topicals

(2019) Matthew R. Beymer et al.   Current HIV/AIDS Reports

Topical Microbicides in HIV Prevention: State of the Promise

(2019) Jared M. Baeten et al.   Annual Review of Medicine

Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis

(2019) Jennifer B. Griffin et al.   PLoS One

Getting to Zero San Francisco

(2019) Susan P. Buchbinder et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Long-acting implants to treat and prevent HIV infection

(2019) Ethel D. Weld et al.   Current Opinion in HIV and AIDS

The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention

(2018) Ariane van der Straten et al.   Journal of the International AIDS Society

Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study

(2018) Andrew E Grulich et al.   Lancet HIV

Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women

(2016) Annalene Nel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

(2016) Jared M. Baeten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1–Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda

(2016) Jared M. Baeten et al.   PLOS MEDICINE

Defining success with HIV pre-exposure prophylaxis

(2015) Jessica E. Haberer et al.   AIDS

Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

(2015) Jeanne M. Marrazzo et al.   NEW ENGLAND JOURNAL OF MEDICINE

HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention

(2014) Deborah Donnell et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial

(2014) Jared M Baeten et al.   LANCET INFECTIOUS DISEASES

Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study

(2014) Robert M Grant et al.   LANCET INFECTIOUS DISEASES

Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women

(2012) Jared M. Baeten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men

(2012) P. L. Anderson et al.   Science Translational Medicine

Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women

(2011) Salim S Abdool Karim et al.   LANCET

Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

(2010) Robert M. Grant et al.   NEW ENGLAND JOURNAL OF MEDICINE